Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3577742
Max Phase: Preclinical
Molecular Formula: C17H12ClN3O2S
Molecular Weight: 357.82
Molecule Type: Small molecule
Associated Items:
ID: ALA3577742
Max Phase: Preclinical
Molecular Formula: C17H12ClN3O2S
Molecular Weight: 357.82
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=S(=O)(Nc1ccc(Cl)cc1)c1ccc2[nH]c3cnccc3c2c1
Standard InChI: InChI=1S/C17H12ClN3O2S/c18-11-1-3-12(4-2-11)21-24(22,23)13-5-6-16-15(9-13)14-7-8-19-10-17(14)20-16/h1-10,20-21H
Standard InChI Key: LGEYYEMBMSKRCQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 357.82 | Molecular Weight (Monoisotopic): 357.0339 | AlogP: 4.17 | #Rotatable Bonds: 3 |
Polar Surface Area: 74.85 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 7.79 | CX Basic pKa: 4.72 | CX LogP: 2.96 | CX LogD: 2.84 |
Aromatic Rings: 4 | Heavy Atoms: 24 | QED Weighted: 0.58 | Np Likeness Score: -1.34 |
1. Gooyit M, Tricoche N, Javor S, Lustigman S, Janda KD.. (2015) Exploiting the Polypharmacology of ß-Carbolines to Disrupt O. volvulus Molting., 6 (3): [PMID:25815157] [10.1021/ml500516r] |
Source(1):